Net buffer load during regional citrate anticoagulated continuous renal replacement therapy
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0315727 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Innas Forsal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Baxter International Inc., Lund, Sweden. Hauptthemen laut MEDLINE: Continuous Renal Replacement Therapy, Citric Acid, Acute Kidney Injury, Anticoagulants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Regionally anticoagulated continuous renal replacement therapy with citrate is the first choice for critically ill patients with acute kidney injury. If citrate that reaches the patient exceeds the metabolic capacity, metabolic alkalosis will follow. Bicarbonate from the treatment fluids will also reach the patient and add to the bicarbonate load. Net buffer load is a parameter calculated by the dialysis machine software from the treatment fluid contents, the fluid flows and the filter properties. Each time the treatment settings are altered the net buffer load will be re-calculated. This parameter is integrated as a static safety parameter in the Prismax version 3 software, and will guide the operator on a possible development of metabolic alkalosis with the current settings.
Methods
Algorithms for estimating the net buffer load were developed. Hourly clinical data from electronic medical records from 60 patients’ continuous renal replacement treatments at the Adult Intensive Care Unit, Skåne University Hospital, Lund, Sweden was used to simulate net buffer load. The relation between net buffer load and acid base status at steady state was evaluated. Net buffer load was also calculated from three previous studies for comparison to our present cohort.
Results
The mean net buffer load was +0.09 ±0.04 mmol/h/kg in the present cohort, and comparable to historic cohorts from literature. We could not establish a correlation to steady state arterial bicarbonate. The pre blood pump citrate containing replacement fluid flow rate was affecting net buffer load most of all parts of the dialysis circuit, with a r 2 Pearson correlation coefficient of 0.65 (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Baxter International Inc., Lund, Sweden.
- Baxter International Inc., Meyzieu, France.
- Baxter International Inc., Deerfield, Massachusetts, United States of America.
- Skåne University Hospital, Lund, Sweden.
ORCID-Profile: Innas Forsal
Zitieren
APA
Forsal, I., Pouchoulin, D., Roos, V., Echeverri, J., & Broman, M. E. (2025). Net buffer load during regional citrate anticoagulated continuous renal replacement therapy. PLOS ONE. https://doi.org/10.1371/journal.pone.0315727
Vancouver
Forsal I, Pouchoulin D, Roos V, Echeverri J, Broman ME. Net buffer load during regional citrate anticoagulated continuous renal replacement therapy. PLOS ONE. 2025. doi:10.1371/journal.pone.0315727
BibTeX
@article{Forsal2025,
author = {Forsal, Innas and Pouchoulin, Dominique and Roos, Viktoria and Echeverri, Jorge and Broman, Marcus Ewert},
title = {Net buffer load during regional citrate anticoagulated continuous renal replacement therapy},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0315727}
}
EUVIMED